Is IFCI overvalued or undervalued?
As of November 7, 2025, IFCI is considered very expensive with a PE ratio of 45.35, significantly overvalued compared to peers like Bajaj Finance and Life Insurance, and has underperformed the Sensex with a year-to-date decline of 12.84%.
As of 7 November 2025, the valuation grade for IFCI has moved from expensive to very expensive, indicating a significant increase in perceived value. The company is currently overvalued based on its financial ratios, with a PE ratio of 45.35, an EV to EBITDA ratio of 10.70, and a PEG ratio of 0.36. These figures suggest that the stock is trading at a premium compared to its earnings growth potential.In comparison to its peers, IFCI's valuation appears excessive, especially when contrasted with Bajaj Finance, which has a PE ratio of 38.09, and Life Insurance, which is valued attractively with a PE of 11.44. This disparity highlights that IFCI's current valuation does not align well with industry standards. Furthermore, the company's recent stock performance has lagged behind the Sensex, with a year-to-date decline of 12.84% compared to a 6.50% gain in the index, reinforcing the notion that IFCI is overvalued.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
